The 5 SVB Critical Questions And Answers For Biotech

Six months ago, I wrote in Forbes how the Fed’s Inflation fight would harm Biotech. With the FDIC takeover of Silicon Valley Bank (SVB) using the receiver, Deposit Insurance National Bank of Santa Clara the judgement has proven to be correct. And what could happen next may be even more disruptive.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive